Avidin has optimized the synthesis of Luciferin ethyl ester, a membrane permeable analog of the primary substrate for the firefly luciferase. This reagent produces 30%
Avidin as part of a European consortium leaded by the Burgos University (Spain) successfully won a H2020 grant (PHC-14-2015) entitled „Novel therapeutic approaches for the
MINICONFERENCE & WORKSHOP Avidin organized a Miniconference & Workshop entitled “TOP LIFE SCIENCE METHODS – Label-free and traditional methods to analyze cellular response to natural
SingleCellProtectTM (Cat# SCP-50, SCP-250) solution is an aqueous, nontoxic reagent that induces cell lysis, stabilizes and protects cellular RNA. It is compatible with reverse transcription,
In cell culturing mycoplasma contamination is a major problem regarding both research and industrial production. Unlike fungal or bacterial infections, mycoplasmal contaminations cannot be detected
New patent, entitled ‘8 Hidroxy-Quinoline Derivatives’ was granted by the Australian Patent Office under patent number 2011256989 on 4th December 2014.
New patent, entitled ‘8 Hidroxy-Quinoline Derivatives’ was granted by the US Patent Office under patent number US 8,871,937 B2 on 28th October 2014.